Jeske A - Search Results

1

Patterns of opioid use among Texas dental practitioners during the COVID-19 pandemic.

Jeske AH, Anderson A, Do KA, Ning J, Ma J, Bruera E. Jeske AH, et al. J Opioid Manag. 2023 Nov-Dec;19(6):523-532. doi: 10.5055/jom.0837. J Opioid Manag. 2023. PMID: 38189194

2

Designing audit and feedback dashboards for dentists to monitor their opioid prescribing.

Tungare S, Gantela S, Kookal KK, Yansane AI, Sedlock E, Jeske A, Johnson T, Walji M. Tungare S, et al. Among authors: jeske a. Int J Med Inform. 2023 Aug;176:105092. doi: 10.1016/j.ijmedinf.2023.105092. Epub 2023 May 22. Int J Med Inform. 2023. PMID: 37267811

3

Provider-directed analgesia for dental pain.

Myers AL, Jeske AH. Myers AL, et al. Among authors: jeske ah. Expert Rev Clin Pharmacol. 2023 May;16(5):435-451. doi: 10.1080/17512433.2023.2206118. Epub 2023 Apr 26. Expert Rev Clin Pharmacol. 2023. PMID: 37083548 Review.

4

Evolution of biofilm-adapted gene expression profiles in lasR-deficient clinical Pseudomonas aeruginosa isolates.

Jeske A, Arce-Rodriguez A, Thöming JG, Tomasch J, Häussler S. Jeske A, et al. NPJ Biofilms Microbiomes. 2022 Feb 14;8(1):6. doi: 10.1038/s41522-022-00268-1. NPJ Biofilms Microbiomes. 2022. PMID: 35165270 Free PMC article.

5

Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy.

Alhallak K, Sun J, Muz B, Jeske A, O'Neal J, Ritchey JK, Achilefu S, DiPersio JF, Azab AK. Alhallak K, et al. Among authors: jeske a. J Cell Mol Med. 2022 Feb;26(3):940-944. doi: 10.1111/jcmm.16885. Epub 2022 Jan 11. J Cell Mol Med. 2022. PMID: 35014164 Free PMC article.

6

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma.

Alhallak K, Jeske A, de la Puente P, Sun J, Fiala M, Azab F, Muz B, Sahin I, Vij R, DiPersio JF, Azab AK. Alhallak K, et al. Among authors: jeske a. Sci Rep. 2021 Sep 29;11(1):19343. doi: 10.1038/s41598-021-98760-9. Sci Rep. 2021. PMID: 34588522 Free PMC article.

7

Nanoparticle T cell engagers for the treatment of acute myeloid leukemia.

Alhallak K, Sun J, Muz B, Jeske A, Yavner J, Bash H, Park C, Lubben B, Adebayo O, Achilefu S, DiPersio JF, Azab AK. Alhallak K, et al. Among authors: jeske a. Oncotarget. 2021 Sep 14;12(19):1878-1885. doi: 10.18632/oncotarget.28054. eCollection 2021 Sep 14. Oncotarget. 2021. PMID: 34548905 Free PMC article.

8

Vector Strategies to Actualize B Cell-Based Gene Therapies.

Jeske AM, Boucher P, Curiel DT, Voss JE. Jeske AM, et al. J Immunol. 2021 Aug 1;207(3):755-764. doi: 10.4049/jimmunol.2100340. J Immunol. 2021. PMID: 34321286 Free PMC article. Review.

9

Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges.

Alhallak K, Sun J, Jeske A, Park C, Yavner J, Bash H, Lubben B, Adebayo O, Khaskiah A, Azab AK. Alhallak K, et al. Among authors: jeske a. Cancers (Basel). 2021 Jun 8;13(12):2853. doi: 10.3390/cancers13122853. Cancers (Basel). 2021. PMID: 34201007 Free PMC article. Review.

10

3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance.

Alhallak K, de la Puente P, Jeske A, Sun J, Muz B, Rettig MP, Sahin I, Weisberg EL, Griffin JD, Reagan JL, DiPersio JF, Azab AK. Alhallak K, et al. Among authors: jeske a. Leuk Lymphoma. 2021 Oct;62(10):2457-2465. doi: 10.1080/10428194.2021.1919657. Epub 2021 May 17. Leuk Lymphoma. 2021. PMID: 33993837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page